F8-IL10

N/A

Report date: 2024/06/21 16:38:51

Base Information

Drug NameF8-IL10

Drug Alias NameDekavil (F8-IL10)DekavilF8-IL10PF-06687234

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-chain FV antibody fragment (scFv)

Mechanisms of ActionInterleukin-10 replacementsAnti-fibronectin

TargetsInterleukin 10 receptorFibronectin

Therapy Area/IndicationsInflammatory Bowel DiseasesColitis, UlcerativeArthritis, Rheumatoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgiumUnited StatesSerbia +[11]

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesPhilogen Spa

China Registration ClassN/A

Develop Information

Active CompaniesPhilogen Spa

Inactive CompaniesPfizer Inc

Active IndicationsArthritis, Rheumatoid

Inactive IndicationsInflammatory Bowel DiseasesColitis, Ulcerative

Other Information

ATC CodeN/A